NDLI: Assessment of subclinical, toxicant-induced hepatic gene expression profiles after low-dose, short-term exposures in mice

Please wait, while we are loading the content...

Use of mixed-effect models and tolerance limits to evaluate control cynomolgus monkey body weight change and variability during preclinical toxicology studies.

Assessing the human carcinogenic potential of tetrahydrofuran: I. Mode of action and human relevance analysis of the male rat kidney tumor

Bioinformatics and the allergy assessment of agricultural biotechnology products: industry practices and recommendations.

Assessment of subclinical, toxicant-induced hepatic gene expression profiles after low-dose, short-term exposures in mice

Anti-tumor efficacy and pre-clinical immunogenicity of IFN 2a-NGR.

The relationship between nicotine dependence scores and biomarkers of exposure in adult cigarette smokers.

Fiber glass exposure and human respiratory system cancer risk: lack of evidence persists since 2001 IARC re-evaluation.

Excipients in medicinal products used in gastroenterology as a possible cause of side effects.

Acute and subacute toxicological evaluation of scutellarin in rodents.

Scientific issues related to Codex Alimentarius goals: a review of principles, with examples.

Protective effects of Chlorella-derived peptide on UVB-induced production of MMP-1 and degradation of procollagen genes in human skin fibroblasts.

One-generation reproductive toxicity study of 2-methylbutane in Sprague–Dawley rats

Case studies to test: A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments.

Melamine induces sperm DNA damage and abnormality, but not genetic toxicity.

Year: 2011 Volume: 60 Issue: 1 Supplementary

Year: 2011 Volume: 59

Year: 2010 Volume: 58

Year: 2010 Volume: 57

Year: 2010 Volume: 56

Year: 2009 Volume: 55

Year: 2009 Volume: 54

Year: 2009 Volume: 53

Year: 2008 Volume: 52

Year: 2008 Volume: 51

Year: 2008 Volume: 50

Year: 2007 Volume: 48

Assessment of subclinical, toxicant-induced hepatic gene expression profiles after low-dose, short-term exposures in mice

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Zheng, Jenny L. Parfett, Craig Williams, Andrew Yagminas, Al Zhou, Gu Douglas, George R. Yauk, Carole L.
Description	Country affiliation: Canada Author Affiliation: Zheng JL ( Mechanistic Studies Division, Safe Environments Programme, Health Canada, Ottawa, Ontario K1A0K9, Canada.)
Abstract	Gene expression profiling that examines critical, toxicologically-relevant gene and signal-response pathways promises to improve risk assessment and safety evaluation of low-dose chemical exposures. As an approach to achieving this goal, mechanistic interpretations based upon gene expression changes that are determinants of adverse toxicological outcomes were applied to the analysis of low-dose gene expression profiles. RNA for expression profiling was obtained from mice given short-term gavage exposures to diminishing doses of four toxicants: 3,3',4,4',5-pentachlorobiphenyl (PCB126), phenobarbital (PB), isoproterenol (IPR), and lead acetate (PbAc). Lowest doses were below the no-observable effects levels established using standard clinical toxicology parameters. Hepatic gene expression profiles were analyzed using a custom, focused oligonucleotide DNA microarray, the HC ToxArray™, containing toxin-responsive and toxicologically-determinant genes. Expression data were compared to changes in conventional clinical chemistry parameters and drug metabolism activities. PCB126 and PB demonstrated a dose-dependent correlation between minimal changes in biochemical markers, hepatic metabolism and induction of gene expression profiles. PbAc exposure gave a small adaptive profile at the highest dose. IPR- and PCB126-induced changes were detected at doses below those required to alter the traditional biochemical endpoints and included genes with causal roles in hepatic toxicity, insulin resistance, atherosclerosis, angiogenesis and hypertension. Likely adverse phenotypic consequences resulting from expression changes lead to assignments of 'Lowest Observed Adverse Transcriptional Expression Levels' (LOATEL) for each agent. These results support the suggestion that altered expression profiles of genes contributing to toxicologically-relevant pathways provide useful tools for reducing uncertainty in establishing no-effect levels and for designing longer-term toxicity studies.
File Format	HTM / HTML
ISSN	02732300
Issue Number	1
Volume Number	60
e-ISSN	10960295
Journal	Regulatory Toxicology and Pharmacology
Language	English
Publisher	Elsevier
Publisher Date	2011-06-01
Publisher Place	Netherlands
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Pharmacology Gene Expression Drug Effects Liver Xenobiotics Toxicity Animals Body Weight Clinical Chemistry Tests Cytochrome P-450 Enzyme System Genetics Metabolism Dose-response Relationship, Drug Gene Expression Profiling Isoproterenol Pathology Liver Function Tests Male Mice Mice, Inbred Strains Microarray Analysis Microsomes, Liver Enzymology Oligonucleotide Array Sequence Analysis Organ Size Organometallic Compounds Phenobarbital Polychlorinated Biphenyls Rna, Messenger Journal Article Research Support, Non-u.s. Gov't
Content Type	Text
Resource Type	Article
Subject	Medicine Toxicology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Polychlorinated biphenyls: a new type of inducer of cytochrome P-448 in the liver.

Primary structure of a cytochrome P-450: coding nucleotide sequence of phenobarbital-inducible cytochrome P-450 cDNA from rat liver.

Dose-response of oridonin on hepatic cytochromes P450 mRNA expression and activities in mice.

Significant interspecies differences in induction profiles of hepatic CYP enzymes by TCDD in bank and field voles.

Effects of choline-deprivation on paracetamol- or phenobarbital-induced rat liver metabolic response.

Hyper- and hypo-induction of cytochrome P450 activities with Aroclor 1254 and 3-methylcholanthrene in Cyp1a2(-/-) mice.

Kinetics of carbon monoxide binding to phenobarbital-induced cytochrome P-450 from rat liver microsomes: a simple bimolecular process.

Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene.

Mechanisms of hydroxylation by cytochrome P-450: metabolism of monohalobenzenes by phenobarbital-induced microsomes.

Assessment of subclinical, toxicant-induced hepatic gene expression profiles after low-dose, short-term exposures in mice

Similar Documents

Polychlorinated biphenyls: a new type of inducer of cytochrome P-448 in the liver.

Primary structure of a cytochrome P-450: coding nucleotide sequence of phenobarbital-inducible cytochrome P-450 cDNA from rat liver.

Dose-response of oridonin on hepatic cytochromes P450 mRNA expression and activities in mice.

Significant interspecies differences in induction profiles of hepatic CYP enzymes by TCDD in bank and field voles.

Effects of choline-deprivation on paracetamol- or phenobarbital-induced rat liver metabolic response.

Hyper- and hypo-induction of cytochrome P450 activities with Aroclor 1254 and 3-methylcholanthrene in Cyp1a2(-/-) mice.

Kinetics of carbon monoxide binding to phenobarbital-induced cytochrome P-450 from rat liver microsomes: a simple bimolecular process.

Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene.

Mechanisms of hydroxylation by cytochrome P-450: metabolism of monohalobenzenes by phenobarbital-induced microsomes.

Assessment of subclinical, toxicant-induced hepatic gene expression profiles after low-dose, short-term exposures in mice